OnCo
trialsTrialActive

First in Human Study of AZD9592 in Solid Tumors

A phase 1 trial of Tilatamig samrotecan, Osimertinib, Fluorouracil and Leucovorin in Head and neck squamous cell carcinoma, run by AstraZeneca, active and no longer recruiting.